These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31900153)

  • 1. Dopamine D
    Chang PK; Chu J; Tsai YT; Lai YH; Chen JC
    J Biomed Sci; 2020 Jan; 27(1):16. PubMed ID: 31900153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D3 receptor blockade rescues hyper-dopamine activity-induced deficit in novel object recognition memory.
    Chang PK; Yu L; Chen JC
    Neuropharmacology; 2018 May; 133():216-223. PubMed ID: 29407766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.
    Pardo M; Abrial E; Jope RS; Beurel E
    Genes Brain Behav; 2016 Mar; 15(3):348-55. PubMed ID: 26749572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus.
    Castorina A; D'Amico AG; Scuderi S; Leggio GM; Drago F; D'Agata V
    Neuroscience; 2013 Oct; 250():546-56. PubMed ID: 23906635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.
    Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T
    Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress.
    Novick AM; Forster GL; Hassell JE; Davies DR; Scholl JL; Renner KJ; Watt MJ
    Neuropharmacology; 2015 Oct; 97():194-200. PubMed ID: 26056032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway.
    Wong P; Sze Y; Chang CC; Lee J; Zhang X
    Transl Psychiatry; 2015 Mar; 5(3):e528. PubMed ID: 25781227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.
    Wang J; Jia Y; Li G; Wang B; Zhou T; Zhu L; Chen T; Chen Y
    Int J Neuropsychopharmacol; 2018 May; 21(5):448-460. PubMed ID: 29390063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged dopamine D
    Luis-Ravelo D; Fumagallo-Reading F; Castro-Hernandez J; Barroso-Chinea P; Afonso-Oramas D; Febles-Casquero A; Cruz-Muros I; Salas-Hernandez J; Mesa-Infante V; Rodriguez-Nuñez J; Gonzalez-Hernandez T
    Pharmacol Res; 2021 Mar; 165():105434. PubMed ID: 33484816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling.
    Dzirasa K; Ramsey AJ; Takahashi DY; Stapleton J; Potes JM; Williams JK; Gainetdinov RR; Sameshima K; Caron MG; Nicolelis MA
    J Neurosci; 2009 Jun; 29(25):8215-24. PubMed ID: 19553461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention.
    Marshall CA; Brodnik ZD; Mortensen OV; Reith MEA; Shumsky JS; Waterhouse BD; España RA; Kortagere S
    Neuropharmacology; 2019 Apr; 148():178-188. PubMed ID: 30633928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.
    Milienne-Petiot M; Geyer MA; Arnt J; Young JW
    Psychopharmacology (Berl); 2017 Mar; 234(6):1017-1028. PubMed ID: 28160035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter is downregulated and its association with chaperone protein Hsc70 is enhanced by activation of dopamine D
    Chang PK; Chien KY; Chen JC
    Brain Res Bull; 2020 Dec; 165():263-271. PubMed ID: 33049353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Di Marzo V; Drago F
    Pharmacol Res; 2010 Jun; 61(6):531-6. PubMed ID: 20149873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9-Mediated Intersectional Knockout of Glycogen Synthase Kinase 3β in D2 Receptor-Expressing Medial Prefrontal Cortex Neurons Reveals Contributions to Emotional Regulation.
    Khlghatyan J; Beaulieu JM
    CRISPR J; 2020 Jun; 3(3):198-210. PubMed ID: 32584144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.
    Young JW; Goey AK; Minassian A; Perry W; Paulus MP; Geyer MA
    Pharmacol Biochem Behav; 2010 Jul; 96(1):7-15. PubMed ID: 20363246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.
    Lavoie J; Hébert M; Beaulieu JM
    Biol Psychiatry; 2014 Jul; 76(2):93-100. PubMed ID: 24138923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Glycogen Synthase Kinase-3β in D
    Li YC; Panikker P; Xing B; Yang SS; Alexandropoulos C; McEachern EP; Akumuo R; Zhao E; Gulchina Y; Pletnikov MV; Urs NM; Caron MG; Elefant F; Gao WJ
    Biol Psychiatry; 2020 Apr; 87(8):745-755. PubMed ID: 31892408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder.
    Barth V; Need AB; Tzavara ET; Giros B; Overshiner C; Gleason SD; Wade M; Johansson AM; Perry K; Nomikos GG; Witkin JM
    J Pharmacol Exp Ther; 2013 Feb; 344(2):501-10. PubMed ID: 23197772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial activation contributes to depressive-like behavior in dopamine D3 receptor knockout mice.
    Wang J; Lai S; Li G; Zhou T; Wang B; Cao F; Chen T; Zhang X; Chen Y
    Brain Behav Immun; 2020 Jan; 83():226-238. PubMed ID: 31626970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.